These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 27454758

  • 1. Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort.
    Zweegers J, Roosenboom B, van de Kerkhof PC, van den Reek JM, Otero ME, Atalay S, Kuijpers AL, Koetsier MI, Arnold WP, Berends MA, Weppner-Parren L, Bijen M, Njoo MD, Mommers JM, van Lümig PP, Driessen RJ, Kievit W, de Jong EM.
    Br J Dermatol; 2017 Mar; 176(3):786-793. PubMed ID: 27454758
    [Abstract] [Full Text] [Related]

  • 2. PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis.
    Carrera CG, Dapavo P, Malagoli P, Naldi L, Arancio L, Gaiani F, Egan CG, Di Mercurio M, Cattaneo A.
    J Dermatolog Treat; 2018 Aug; 29(5):481-486. PubMed ID: 29058948
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.
    Zweegers J, Groenewoud JMM, van den Reek JMPA, Otero ME, van de Kerkhof PCM, Driessen RJB, van Lümig PPM, Njoo MD, Ossenkoppele PM, Mommers JM, Koetsier MIA, Arnold WP, Andriessen MPM, Kuijpers ALA, Berends MAM, Kievit W, de Jong EMGJ.
    Br J Dermatol; 2017 Apr; 176(4):1001-1009. PubMed ID: 27579864
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C, Marshman G, Grillo M, Stanford T.
    Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of biologic therapies in psoriasis vulgaris.
    Mala R, Fida M, Jorgaqi E, Vasili E.
    Dermatol Ther; 2019 Jul; 32(4):e12936. PubMed ID: 30983095
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis.
    Puig L.
    J Clin Pharm Ther; 2015 Apr; 40(2):131-4. PubMed ID: 25627250
    [Abstract] [Full Text] [Related]

  • 12. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
    Abrouk M, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T.
    J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
    [Abstract] [Full Text] [Related]

  • 13. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
    Van Lümig PP, Lecluse LL, Driessen RJ, Spuls PI, Boezeman JB, van de Kerkhof PC, De Jong EM.
    Br J Dermatol; 2010 Oct; 163(4):838-46. PubMed ID: 20649798
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort.
    Van Muijen ME, Thomas SE, Groenewoud HMM, Otero ME, Ossenkoppele PM, Njoo MD, Dodemont SRP, Kop EN, Berends MAM, Koetsier MIA, Mommers JM, Körver JEM, Tupker RA, De Bruin-Weller MS, Weppner-Parren LJMT, Peters B, Kleinpenning MM, Kuijpers ALA, Arnold WP, Van Lümig PPM, Van den Reek JMPA, De Jong EMGJ.
    Acta Derm Venereol; 2022 May 16; 102():adv00712. PubMed ID: 35356990
    [Abstract] [Full Text] [Related]

  • 18. Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry.
    van der Schoot LS, van den Reek JMPA, Groenewoud JMM, Otero ME, Njoo MD, Ossenkoppele PM, Mommers JM, Koetsier MIA, Berends MAM, Arnold WP, Peters B, Andriessen MPM, Den Hengst CW, Kuijpers ALA, de Jong EMGJ.
    J Eur Acad Dermatol Venereol; 2019 Oct 16; 33(10):1913-1920. PubMed ID: 31177583
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Frequency and outcomes of treatment dose escalation with biologics in moderate-to-severe psoriasis: a Swedish register study.
    Svedbom A, Wennerström C, Hjelm F, Tjärnlund A, Ståhle M.
    J Dermatolog Treat; 2024 Dec 16; 35(1):2398170. PubMed ID: 39229963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.